Ticker LaunchLaw firm
Norton Rose Fulbright
Norton Rose Fulbright is named in the Legal Matters section of 3 US IPO and 5 SPAC IPO prospectuses tracked by Ticker Launch since 2019, as company counsel on 5 and underwriters' counsel on 3.
US IPOs3
SPAC IPOs5
Deals by year: 2026: 5 · 2025: 1 · 2024: 1 · 2021: 1
Deals
| Company | Type | Date | Size | Role |
|---|---|---|---|---|
| Southern Cross Acquisition II Corp. | SPAC IPO | Aug 26, 2026 | $75M | Underwriters' counsel |
| Southern Cross Acquisition I Corp. | SPAC IPO | Jul 21, 2026 | — | Underwriters' counsel |
| Burtech Acquisition Corp II | SPAC IPO | May 26, 2026 | $80M | Underwriters' counsel |
| Optimi Health Corp. | IPO | May 20, 2026 | — | Company counsel |
| SPACSphere Acquisition Corp. | SPAC IPO | Feb 6, 2026 | $150M | Company counsel |
| Crown Reserve Acquisition Corp. I | SPAC IPO | Nov 6, 2025 | $150M | Company counsel |
| FibroBiologics, Inc. | IPO | Jan 31, 2024 | — | Company counsel |
| Third Coast Bancshares, Inc. | IPO | Nov 9, 2021 | $87.5M | Company counsel |
See where Norton Rose Fulbright ranks: US IPOs · SPAC IPOs
Track Norton Rose Fulbright's next deals
Subscribers get each new filing and pricing the morning after, with alerts and Excel export.